PTGDR2 and acute myeloid leukemia: indicated that in acute myeloid leukemia, PTGDR2 inhibited the KRAS-mediated MAPK and PI 3 K/AKT/mTOR signaling pathways, thereby promoting apoptosis of LICs (26).